Skip to main content

Clifford Chance

Clifford Chance
All
Benjamin Sibbett

Benjamin Sibbett

Partner

Partner
Benjamin Sibbett

Benjamin Sibbett's practice encompasses a broad range of domestic and cross-border M&A transactions for a "roster of top corporate clients." He has particular expertise leading multi-jurisdictional and multi-practice teams supporting non-US corporate clients that are investing in the United States. 

He has been independently recognized in Chambers USA (Corporate/M&A), IFLR1000, The Legal 500 US (Corporate/M&A) and The Legal 500 Latin America (Corporate/M&A), with sources saying that he is "very client oriented," “smart, responsive and practical” and "always a pleasure to work with."

Ben is Head of the Americas Corporate practice, Co-Head of the US M&A practice and a member of the firm's Americas Management Committee and Global Corporate Leadership Group. He served for several years on the firm's global Audit & Risk Committee and Partnership Council.

  • Spectris in its acquisition of SciAps (pending)
  • Nord Anglia Education in its acquisition of The Avenues World Schools in New York and Brazil
  • Unilever in the sale of its Elida Beauty business to Yellow Wood Partners
  • Royal DSM in the sale of its Protective Materials business to Avient Corporation
  • Gamesys Group in its business combination with Bally's
  • Henkel in the sale of its thermal clad dielectric materials business to Polytronics Technology
  • Royal Ten Cate and Gilde Buy Out Partners on the sale of TenCate Geosynthetics Holding to Solmax
  • NSK on its acquisition of Brüel & Kjær Vibro from Spectris
  • Symrise (FRA: SY1) in connection with:
    • its acquisition of American Dehydrated Foods and International Dehydrated Foods
    • the sale of its chicken-based food ingredients business to Kerry
  • Textron (NYSE: TXT) in connection with:
    • its acquisition of ETOPS
    • the joint venture between its subsidiary, TRU Simulation + Training, and FlightSafety International
  • Europcar Mobility Group (EPA: EUCAR) in connection with:
    • its acquisition of Fox Rent A Car
    • certain aborted acquisitions, and various commercial matters, in the United States
  • Exact Group on the sale of Specialized Solutions to Apax Partners
  • Gemalto in its acquisition of 3M's identity management business
  • KUKA in its takeover by China's Midea Group
  • Geodis in connection with:
    • its acquisition of Ozburn-Hessey Logistics from Welsh Carson
    • certain aborted acquisitions, and various commercial matters, in the United States
  • S&P Global (NYSE: SPGI) in connection with:
    • the sale of Standard & Poor’s Securities Evaluations and Credit Market Analysis to Intercontinental Exchange (NYSE: ICE)
    • the sale of QuantHouse to a company owned by Pierre Feligioni, one of QuantHouse's original founders
    • the sale of its education business to Apollo
    • certain other corporate and commercial matters across multiple jurisdictions
  • Hearst Corporation in connection with:
    • its acquisition of Avinode Group and Aviation FBO Software Products from World Kinect Corporation
    • its acquisition of DV01
    • its acquisition of Noregon Systems
    • its acquisition of Bring a Trailer Media
    • its acquisition of FlightBridge
    • its acquisition of Lagardere's International press and magazine business
    • its acquisition of CAMP Systems International from GTCR
    • its acquisition of a controlling stake in KUBRA Data Transfer
    • its AwesomenessTV joint venture with Dreamworks Animation
    • its acquisition Milliman Care Guidelines
    • its acquisition of Homecare Homebase
    • its acquisition of MedHOK
    • its acquisition of certain Connecticut print and digital assets of 21st Century Media Newspaper
    • its acquisition of Hearst-Argyle Television (NYSE: HTV)
  • Audi, BMW and Daimler in connection with their joint acquisition of HERE, a digital mapping business, from Nokia
  • AMC Networks (NASDAQ: AMCX) in connection with:
    • its acquisition of Chellomedia from Liberty Global (NASDAQ: LBTYA)
    • certain aborted acquisitions
    • numerous other commercial, tax and IP matters across multiple jurisdictions
  • Informa (LON: INF) in connection with:
    • the combination of Informa Tech’s digital businesses with TechTarget (NASDAQ: TTGT) (pending)
    • its acquisition of Winsight, a specialist B2B events, data and media group
    • the sale of its financial intelligence provider business, Emerging Portfolio Funds Research, to Montagu 
    • the sale of its maritime intelligence business to Montagu
    • the sale of its pharma intelligence business to Warburg Pincus
    • the sale of its asset intelligence business to Aurora Capital-backed Randall-Reilly
    • its acquisition of Penton Business Media from MidOcean Partners and Wasserstein
    • the sale of its worldwide corporate training businesses to Providence Equity Partners
    • its takeover of UBM
    • its acquisition of the exhibition business of Hanley Wood Exhibitions
    • its acquisition of Yachting Promotions Inc. from Active Interest Media
    • certain other completed and aborted transactions in the United States
  • Summit Health in its sale to Quest Diagnostics
  • Pfizer (NYSE: PFE) in connection with:
    • the acquisition of a biologics drug substance manufacturing facility from Abzena
    • the carve out and sale of its consumer healthcare business to, and joint venture with, GlaxoSmithKline
    • the carve out and sale of its generics business (Upjohn) to, and joint venture (Viatris) with, Mylan
    • the carve out and sale of its global infusion systems business to ICU Medical
    • the sale of Hospira Boulder to CordenPharma
    • its acquisition of B-Total from Johnson & Johnson
    • the EU-mandated sale of certain of its pharmaceutical assets to Hikma Pharmaceuticals
    • the sale of its bulk insulin and related manufacturing facilities to MannKind Corporation
    • the sale of certain of its consumer healthcare manufacturing assets to Fareva
    • the sale of certain of its consumer healthcare manufacturing assets to UPM Pharmaceuticals
    • the sale of certain of its API manufacturing assets to ICIG
    • various multi-jurisdictional restructurings

News and client work

View all news and client work featuring Benjamin Sibbett

Contact details

Career and qualifications

  • Brigham Young University (BA) 1996
  • Fordham University School of Law (JD) 1999
  • Joined Clifford Chance 1999
  • Admitted as an Attorney-at-Law in New York 2000
  • Partner since 2008

Professional bodies

  • Member of the American Bar Association
  • Member of the International Bar Association

Awards and citations

  • "Ben is a consummate practitioner."
    "Ben has significant gravitas and stands out for being calm, measured and authoritative."
    "One of Ben’s key skills is dealing with counterparties both from a business and legal perspective. He has a good way of explaining complex issues in ways that is understandable.    "
    Chambers USA 2024
  • Highly Regarded Lawyer
    IFLR 2023
  • Highly Regarded lawyer
    IFLR1000 2022 –  United States
  • Benjamin Sibbett is called upon by a roster of top corporates to advise on domestic and cross-border M&A. His broad industry expertise covers pharmaceuticals and media, among others. "Ben is very client-oriented and is an excellent manager of people.“ "He shows good responsiveness and direct communication."
    Chambers USA 2022: Corporate/M&A: Highly Regarded (New York) – Band 2
  • ‘The performance of Benjamin Sibbett and his team was exceptional.’
    Legal 500 US 2021: Corporate/M&A: Large Deals ($1bn+)
  • Benjamin Sibbett is called upon by a roster of top corporates to advise on domestic and cross-border M&A. His broad industry expertise covers pharmaceuticals and media, among others."He is always a pleasure to work with. He is thoughtful and considerate and his advice is concise and direct." "He pays attention to the details and provides a very good customer service."
    Chambers USA 2021: Corporate/M&A - New York: Band 6
  • "..takes the time to listen to the issues of the transaction, helps explore the issues both legally and from the business perspective given his wealth of experience in transactions and has a special gift in explaining to the counterparty the complicated legal issues their own counsel often cannot articulate effectively."
    Legal 500 USA 2019: United States: M&A/Corporate and Commercial
  • Highly Regarded – New York
    IFLR1000 US 2020: M&A
  • Highly Regarded – New York
    IFLR1000 US 2019: M&A
  • Recognized practitioner
    Chambers USA 2019, Corporate/M&A
  • Highly regarded
    IFLR 1000 2019
  • Recognized practitioner
    Chambers USA 2018, Corporate/M&A

    Toolkits & Client Log-in